Credits Available: 4.75 AMA PRA Category 1 Credit™/ MOC Points

Description: This curriculum examines the latest advancements in antibody-drug conjugate (ADC) therapy for metastatic triple-negative breast cancer (mTNBC) and HER2-low (HER+/HER2-) breast cancer. It provides insights into mechanisms of action, emerging clinical data, and strategies for integrating ADCs into treatment regimens to improve patient outcomes. Expert-led discussions and case-based learning will support clinicians in individualizing therapy and addressing real-world challenges in ADC use.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology

La-Urshalar Brock

Emory Healthcare Winship Cancer Institute
Family Nurse Practitioner and PhD Candidate (nursing research)

I am a family nurse practitioner at Winship Cancer Institute specializing in breast and Gyn oncology. Prior to this I worked as a certified nurse midwife for a private practice. I'm starting the PhD program with Emory university Nell Hodgson Woodruff school of Nursing in the Fall 2022 and will be focusing on oncology survivorship and distress symptoms.